The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a promising development. Unlike subcutaneous injections, this method offers a simpler way to administer GLP-1 https://ihannaueyp736641.blogrelation.com/47597248/glp-1-patches-a-innovative-approach-to-blood-sugar-management